Niagen Bioscience, Inc. (NAGE) › Capital ExpendituresNiagen Bioscience, Inc. (NAGE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $150.7K2012: $24.6K2013: $137.3K2015: $123.1K2016: $1.50M2017: $1.17M2018: $1.32M2019: $743.0K$743.0K2011Capital Expenditures (USD)2019Fiscal YearCapital ExpendituresChange YoY2019$743.0K-43.8%2018$1.32M+13.2%2017$1.17M-22.5%2016$1.50M+1122.6%2015$123.1K—2013$137.3K+459.4%2012$24.6K-83.7%2011$150.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share